Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Infective Endocarditis Trial Backs Less Intense Antibiotic Approach

(MedPage Today) -- Shorter antibiotic treatment worked better in clinically stabilized patients with infective endocarditis on the left side of the heart, even though the risk of infection relapse may be greater, according to the open-label randomized...

Infective Endocarditis Trial Backs Less Intense Antibiotic Approach

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy

Under the agreement, Andelyn will transition Genprex's adeno-associated virus (AAV)-based diabetes gene therapy candidate with process optimization, scale-up, and IND-enabling and clinical-stage…

  • Andelyn Biosciences to scale up manufacturing for Genprex's diabetes gene therapy
  • Therapy aims to deliver Pdx1 and MafA genes to pancreas via AAV vector
  • Andelyn's expertise to optimize processes and prepare therapy for clinical trials

More from Tuesday 1 September →